2008 Journal of Natural Products, 2008, Vol. 71, No. 12
Zub´ıa et al.
in normal phase and LiChrosorb RP-18 columns in reversed phase,
using a differential refractometer RI-71. All solvents were spectroscopic
grade or were distilled prior to use.
18.2 (CH3, Me-14), signals marked with an asterisk may be inter-
changed; HRCIMS(+) m/z 295.1597 (calcd for C16H25NO2S, 295.1606).
Axinythiocyanate A (3): colorless oil; [R]25D +39.7 (c 0.1, CHCl3);
UV (MeOH) λmax (log ε) 233 (3.23) nm; IR (film) νmax 2148 cm-1; 1H
NMR (CDCl3, 600 MHz) δ 5.37 (1H, br s, H-2), 5.09 (1H, tsept, J )
7.2, 1.4 Hz, H-10), 2.10 (3H, m, H-1, H2-9), 2.02 (2H, m, H2-4), 1.98
(1H, m, H-1), 1.93 (1H, m, H-5eq), 1.88 (1H, m, H-6), 1.81 (1H, m,
H-8), 1.77 (1H, m, H-8), 1.69 (3H, d, J ) 0.8 Hz, Me-12), 1.65 (3H,
br s, Me-13), 1.63 (3H, br s, Me-15), 1.51 (3H, s, Me-14), 1.38 (1H,
dddd, J ) 12.1, 12.1, 12.1, 5.6 Hz, H-5ax); 13C NMR (CDCl3, 150
MHz) δ 134.1 (C, C-3), 132.8 (C, C-11), 122.7 (CH, C-10), 119.7
(CH, C-2), 112.2 (C, -SCN), 63.7 (C, C-7), 42.5 (CH, C-6), 38.9 (CH2,
C-8), 30.9 (CH2, C-4), 27.2 (CH2, C-1), 25.7 (CH3, Me-12), 24.6 (CH2,
C-5), 23.8 (CH3, Me-14), 23.1 (CH2, C-9), 23.1 (CH3, Me-13), 17.7
(CH3, Me-15); CIMS m/ z 263 (4) [M]+, 205 (78), 204 (27), 189 (9),
69 (100); HRCIMS(+) m/z 263.1694 (calcd for C16H25NS, 263.1708).
Collection and Identification. Specimens of Axinyssa isabela6 (order
Halichondrida, family Halichondriidae) were collected by hand using
scuba in Isla Isabel (Gulf of California, Mexico) and immediately
frozen. A voucher specimen is deposited in the Sponge Collection of
the UNAM under the code LEB-ICML-UNAM-56.
Extraction and Isolation. The extraction of the sponge and the
column chromatography of the resulting extract has been previously
described.5 The fraction of the general chromatography eluted with
hexanes/Et2O (95:5) was chromatographed over a silica gel column
using hexanes and hexanes/Et2O mixtures (99:1 to 80:20) as eluants.
Repeated purifications of selected fractions by normal-phase HPLC
using hexanes or hexanes/EtOAc (99:1) yielded acanthene B (10)7 (5.3
mg, 1.9 × 10-3 % dry wt), 118 (3.6 mg, 1.3 × 10-3 % dry wt), 3 (9.7
mg, 3.5 × 10-3 % dry wt), 129 (5.0 mg, 1.8 × 10-3 dry wt), 1310 (5.5
mg, 2.0 × 10-3 % dry wt), and 9 (4.5 mg, 1.6 × 10-3 % dry wt). The
fraction of the general chromatography eluted with hexanes/Et2O (90:
10) was further separated over a silica gel column using hexanes/Et2O
mixtures (92:8 to 80:20) as eluants. Repeated separations of selected
fractions by normal-phase HPLC (hexanes/EtOAc, 94:6 or 93:7)
afforded compounds 1 (1.2 mg, 4.3 × 10-4 % dry wt) and 2 (3.8 mg,
1.3 × 10-3 % dry wt). The fraction of the general chromatography
eluted with hexanes/Et2O (80:20) was subjected to column chroma-
tography eluted with hexanes/Et2O mixtures (90:10 to 50:50). Separa-
tions of selected fractions by normal-phase HPLC (hexanes/EtOAc,
84:16) afforded compound 8 (2.5 mg, 8.9 × 10-4 % dry wt). The
fraction of the general chromatography eluted with hexanes/Et2O (70:
30) was chromatographed over a silica gel column eluted with hexanes/
Et2O mixtures (85:15 to 60:40). Subsequent purification of selected
fractions by normal-phase HPLC (hexanes/EtOAc, 70:30) yielded
compound 7 (3.5 mg, 1.2 × 10-3 % dry wt). The fractions of the general
chromatography eluted with hexanes/Et2O (30:70, 20:80) and Et2O were
joined and chromatographed over a silica gel column eluted with
hexanes/Et2O mixtures (30:70 and 20:80) and then Et2O. The fraction
eluted with hexanes/Et2O (30:70) was further separated by HPLC in
normal (hexanes/EtOAc, 70:30) and reversed phase (MeOH/H2O, 80:
20) to yield compound 6 (2.0 mg, 7.1 × 10-4 % dry wt). The fraction
eluted with hexanes/Et2O (20:80) was subjected to repeated HPLC
separations in normal-phase (hexanes/EtOAc, 60:40) and reversed-phase
Axinysone A (4): colorless oil; [R]25 +254.0 (c 0.1, CHCl3); UV
D
(MeOH) λmax (log ε) 232 (3.93) nm; IR (film) νmax 3404, 1639 cm-1
;
1H NMR (CDCl3, 600 MHz) see Table 1; 13C NMR (CDCl3, 150 MHz)
see Table 1; EIMS m/ z 234 (50) [M]+, 219 (21), 216 (88), 201 (100);
HRCIMS(+) m/z 235.1696 [M + H]+ (calcd for C15H23O2, 235.1698).
Axinysone B (5): colorless oil; [R]25 +108.0 (c 0.1, CHCl3); UV
D
(MeOH) λmax (log ε) 232 (3.96) nm; IR (film) νmax 3400, 1641 cm-1
;
1H NMR (CDCl3, 600 MHz) δ 5.86 (1H, d, J ) 1.3 Hz, H-9), 4.38
(1H, dd, J ) 3.0, 3.0 Hz, H-1), 1.99 (1H, dddd, J ) 14.2, 3.0, 3.0, 3.0
Hz, H-2eq), 1.84 (1H, dddd, J ) 13.2, 12.9, 12.9, 3.0 Hz, H-3ax),
1.79 (1H, dd, J ) 7.9, 1.3 Hz, H-7), 1.77 (1H, m, H-4), 1.58 (1H,
dddd, J ) 14.2, 13.2, 3.6, 3.0 Hz, H-2ax), 1.42 (1H, d, J ) 7.9 Hz,
H-6), 1.40 (1H, m, H-3eq), 1.36 (3H, s, Me-14), 1.21 (3H, s, Me-12),
1.19 (3H, s, Me-13), 1.09 (3H, d, J ) 6.6 Hz, Me-15); 13C NMR
(CDCl3, 150 MHz) δ 197.2 (C, C-8), 165.2 (C, C-10), 127.3 (CH, C-9),
73.2 (CH, C-1), 40.3 (CH, C-6), 39.0 (C, C-5), 38.8 (CH, C-4), 36.4
(CH, C-7), 32.7 (CH2, C-2), 29.8 (CH3, Me-12), 25.4 (C, C-11), 24.9
(CH2, C-3), 24.6 (CH3, Me-14),16.2 (CH3, Me-15), 16.1 (CH3, Me-
13); EIMS m/z 234 (16) [M]+, 219 (14), 216 (40), 201 (72), 173 (36),
149 (57), 105 (80), 91 (100); HRCIMS(+) m/z 235.1685 [M + H]+
(calcd for C15H23O2, 235.1698).
Axinysone C (6): colorless oil; [R]25 +139.0 (c 0.1, CHCl3); UV
D
(MeOH) λmax (log ε) 232 (3.94) nm; IR (film) νmax 3382, 1643 cm-1
;
1H NMR (CDCl3, 600 MHz) δ 7.93 (1H, br s, OOH), 5.96 (1H, d, J )
1.3 Hz, H-9), 4.47 (1H, dd, J ) 2.7, 2.7 Hz, H-1), 2.16 (1H, m, H-2eq),
1.83 (1H, dd, J ) 7.9, 1.3 Hz, H-7), 1.80 (1H, m, H-4), 1.62 (2H, m,
H-2ax, H-3ax), 1.44 (1H, d, J ) 7.9 Hz, H-6), 1.40 (1H, m, H-3eq),
1.31 (3H, s, Me-14), 1.22 (3H, s, Me-12), 1.22 (3H, s, Me-13), 1.08
(3H, d, J ) 6.6 Hz, Me-15); 13C NMR (CDCl3, 150 MHz) δ 196.7 (C,
C-8), 159.8 (C, C-10), 130.6 (CH, C-9), 85.9 (CH, C-1), 40.1 (CH,
C-6), 39.0 (C, C-5), 38.6 (CH, C-4), 36.3 (CH, C-7), 29.8 (CH3, Me-
12), 29.4 (CH2, C-2), 25.4 (C, C-11), 23.4 (CH2, C-3), 23.3 (CH3, Me-
14), 16.2 (CH3, Me-13), 16.2 (CH3, Me-15); EIMS m/z 251 (1) [M +
H]+, 217 (3), 109 (40), 59 (100); HRCIMS(+) m/z 251.1644 [M +
H]+ (calcd for C15H23O3, 251.1647).
(MeOH/H2O, 65:35) to obtain compounds 5 (16.2 mg, 5.8 × 10-3
%
dry wt) and 4 (16.4 mg, 5.8 × 10-3 % dry wt).
Axinisothiocyanate M (1): colorless oil; [R]25D -40.8 (c 0.1, CCl4);
UV (MeOH) λmax (log ε) 243 (3.09) nm; IR (film) νmax 3466, 2082
cm-1; 1H NMR (CDCl3, 600 MHz) δ 5.07 (1H, br s, H-13a), 4.85 (1H,
dq, J ) 1.3, 1.3 Hz, H-13b), 2.08 (1H, dd, J ) 13.0, 2.9 Hz, H-5),
2.03 (1H, dddd, J ) 13.2, 3.3, 3.3, 1.5 Hz, H-3eq), 1.85 (3H, br s,
Me-12), 1.82 (1H, ddd, J ) 13.2, 13.2, 4.8 Hz, H-3ax), 1.76 (1H, ddd,
J ) 14.0, 13.8, 4.2 Hz, H-8ax), 1.73 (1H, dd, J ) 13.4, 13.0 Hz, H-6ax),
1.64 (1H, m, H-9ax), 1.61 (1H, m, H-6eq), 1.55 (2H, m, H2-2), 1.48
(1H, dddd, J ) 14.0, 3.8, 2.7, 2.7 Hz, H-8eq), 1.43 (1H, m, H-1eq),
1.31 (3H, s, Me-15), 1.23 (2H, m, H-1ax, H-9eq), 0.90 (3H, s, Me-
14); 13C NMR (CDCl3, 150 MHz) δ 151.8 (C, C-11), 109.4 (CH2, C-13),
74.4 (C, C-7), 64.9 (C, C-4), 47.4 (CH, C-5), 41.9 (CH2, C-3), 40.0*
(CH2, C-1), 39.9* (CH2, C-9), 34.4 (C, C-10), 32.9 (CH2, C-6), 31.8
(CH2, C-8), 22.1 (CH3, Me-15), 19.0 (CH3, Me-12), 18.9 (CH2, C-2),
18.1 (CH3, Me-14), signals marked with an asterisk may be inter-
changed; CIMS m/ z 279 (6) [M]+, 221 (36), 220 (20), 203 (100);
HRCIMS(+) m/z 279.1635 (calcd for C16H25NOS, 279.1657).
Axinysone D (7): white solid; [R]25D -39.5 (c 0.1, CHCl3); IR (film)
1
νmax 3436, 1690 cm-1; H NMR (CDCl3, 600 MHz) see Table 1; 13C
NMR (CDCl3, 150 MHz) see Table 1; EIMS m/z 252 (3) [M]+, 237
(2), 234 (2), 219 (2), 139 (13), 127 (49), 126 (88), 111 (100);
HRCIMS(+) m/z 252.1719 (calcd for C15H24O3, 252.1725).
Axinysone E (8): colorless oil; [R]25 +84.3 (c 0.07, CHCl3); UV
D
(MeOH) λmax (log ε) 242 (3.87) nm; IR (film) νmax 1670 cm-1; 1H NMR
(CDCl3, 400 MHz) see Table 1; 13C NMR (CDCl3, 100 MHz) see Table
1; CIMS m/z 233 (89) [M + H]+, 217 (47), 203 (45), 161 (84), 91
(100); HRCIMS m/z 233.1529 [M + H]+ (calcd for C15H21O2,
233.1541).
Axinisothiocyanate N (2): colorless oil; [R]25 -75.7 (c 0.05,
D
Axinynitrile A (9): white solid; [R]25 +70.0 (c 0.1, CHCl3); IR
CHCl3); UV (MeOH) λmax (log ε) 244 (3.21) nm; IR (film) νmax 3416,
D
1
2090 cm-1; H NMR (CDCl3, 400 MHz) δ 7.32 (br s, -OOH), 5.07
(film) νmax 2236 cm-1; H NMR (CDCl3, 600 MHz) see Table 1; 13C
1
(1H, br s, H-13a), 5.03 (1H, br s, H-13b), 2.18 (1H, ddd, J ) 13.7,
2.5, 2.5 Hz, H-6eq), 2.03 (1H, dddd, J ) 13.1, 3.2, 3.2, 1.5 Hz, H-3eq),
1.97 (1H, dd, J ) 13.1, 2.5 Hz, H-5), 1.85 (1H, m, H-8eq), 1.85 (3H,
br s, Me-12), 1.81 (1H, ddd, J ) 13.1, 13.1, 4.6 Hz, H-3ax), 1.64 (1H,
ddd, J ) 13.9, 13.9, 4.2 Hz, H-8ax), 1.62 (1H, dd, J ) 13.7, 13.1 Hz,
H-6ax),1.57 (2H, m, H2-2), 1.52 (1H, m, H-9ax), 1.44 (1H, m, H-1eq),
1.31 (3H, s, Me-15), 1.21 (2H, m, H-1ax, H-9eq), 0.91 (3H, s, Me-
14); 13C NMR (CDCl3, 100 MHz) δ 148.0 (C, C-11), 112.1 (CH2, C-13),
85.2 (C, C-7), 64.9 (C, C-4), 47.5 (CH, C-5), 41.9 (CH2, C-3), 39.9*
(CH2, C-1), 39.8* (CH2, C-9), 34.5 (C, C-10), 28.1 (CH2, C-8), 27.3
(CH2, C-6), 21.7 (CH3, Me-15), 18.8 (CH2, C-2), 18.7 (CH3, Me-12),
NMR (CDCl3, 150 MHz) see Table 1; EIMS m/ z 229 (36), 214 (47),
186 (95), 130 (100); HRCIMS(+) m/z 229.1825 (calcd for C16H23N,
229.1830).
Synthesis of the (R)-MPA Ester 4r. A solution of 4 (0.8 mg, 3.4
× 10-3 mmol) in 0.25 mL of CH2Cl2 was treated with CH2Cl2 solutions
of N,N′-dicyclohexylcarbodiimide (2.2 mg, 0.011 mmol in 0.25 mL),
N,N-dimethylaminopyridine (0.9 mg, 7.4 × 10-3 mmol in 0.25 mL),
and (R)-R-methoxy-R-phenylacetic acid (1.8 mg, 0.011 mmol in 0.25
mL) and stirred at room temperature for 5 h. The reaction mixture was
purified over a preparative TLC (hexanes/EtOAc, 1:1) to obtain 1.2
1
mg of the (R)-MPA ester 4r: H NMR (CDCl3, 600 MHz; selected